Board Leadership & Expert Speaking
With over 25 years of experience building and scaling biotech companies, I speak on what it takes to lead science-driven ventures to commercial success. Whether addressing executives, academic institutions, or investors, I offer grounded insights from the front lines of innovation.
“I serve on boards and advisory roles where biotech meets innovation, and I speak on the future of healthcare, investment strategy, and biotech leadership.”
Dr. Stella K. Vnook
Global Biotech CEO
Board Experience
Guiding Innovation Where Biotech Meets Strategy
Board Chair, FireFly Neuroscience
Providing strategic oversight for a pioneering neurodiagnostic company transforming mental health assessment through AI-enabled brain mapping.
Advisor to University-Born Biotechs
Advising academic spinouts at the intersection of translational science and commercialization.
EIR: Penn State, ECU, Brainstorm Labs
Providing executive mentorship, strategic guidance, and operational support within biotech-focused innovation hubs and accelerator programs.
Speaking Engagements
Sharing Strategic Insights With Audiences Across Biotech, Academia, and Investment
Entrepreneurs & Healthcare Executives
Insights on building, funding, and scaling biotech ventures — from validation to global commercialization — drawn from oncology, neurotech, and diagnostics leadership.
Academia & Government
Perspectives on bridging research and commercialization, including public-private collaboration, policy development, and translational strategy.
VC, PE & Family Office
Guidance on de-risking early-stage platforms, scaling operations, and creating investor-grade biotech assets primed for M&A or IPO.
Subject Matter Expertise
Dr. Stella K. Vnook is an Expert Speaker On
From Startup to Market: Executing Across the Biotech Lifecycle
A proven model for advancing biotech platforms from asset validation to regulatory strategy and market launch — including oncology, gene editing, and regenerative medicine.
Leadership for the Future of Healthcare
A strategic approach to biotech leadership — integrating science, capital, and commercialization across global markets.
Fractional C-Suite & Strategic Execution
How Agile Consulting Group helps biotech ventures execute with speed and precision through fractional leadership, interim C-suite expertise, and operational scaling.